NCT04668014View on ClinicalTrials.gov

The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions

Clostridioides Difficile Infection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04668014 - The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection | Biotech Hunter | Biotech Hunter